Clinical trial
Immune Response & Safety of a Hepatitis A Vaccine Given Together With a…
NCT00197002 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00197002 |
|---|---|
| Title | Immune Response & Safety of a Hepatitis A Vaccine Given Together With a Pneumococcal Vaccine in Healthy Children 15 m of Age |
| Official title | A Phase IIIb, Open, Randomized, Controlled, Multicenter Study of the Immunogenicity and Safety of GSK Biologicals' Inactivated Hepatitis A Vaccine Administered on a 0-6 Mth Schedule Concomitantly With Wyeth Lederle's Pneumococcal Conjugate Vaccine in Healthy Children 15 Months of Age |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hepatitis A |
| Intervention type | Biological |
| Interventions | GSK Biologicals 2-dose inactivated hepatitis A vaccine (Havrix), Prevnar™ |
| Enrollment | 521 |
| Start date | Sep 11, 2003 |
| Primary completion | Jan 16, 2006 |
| Completion | Jan 16, 2006 |
| First posted | Sep 20, 2005 |
| Last update posted | Aug 6, 2018 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: